Pic: Getty Images
Top 10 at 11: Which biotechs are up after positive study results and deals?
News
share
Stockhead’s Top 10 at 10, published each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.
It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.
WINNERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Code | Description | Last | % | Volume | MktCap |
|---|---|---|---|---|---|
| NYR | Nyrada Inc | 0.05 | 163% | 3,875,113 | $2,964,165.30 |
| BMO | Bastion Minerals | 0.0125 | 39% | 12,409,284 | $2,802,996.78 |
| IS3 | I Synergy Group Ltd | 0.008 | 33% | 25,000 | $1,824,482.21 |
| PPG | Pro-Pac Packaging | 0.26 | 30% | 3,849 | $36,337,542.20 |
| ATH | Alterity Therap Ltd | 0.005 | 25% | 2,153,508 | $17,531,018.96 |
| ROG | Red Sky Energy. | 0.005 | 25% | 1,680,099 | $21,688,908.79 |
| TOU | Tlou Energy Ltd | 0.037 | 23% | 28,766 | $32,296,101.51 |
| PAA | PharmAust Limited | 0.465 | 22% | 3,192,296 | $147,142,287.10 |
| HMD | Heramed Limited | 0.023 | 21% | 479,293 | $6,104,019.63 |
| 5EA | 5E Advanced | 0.27 | 20% | 1,192,208 | $70,463,535.75 |
Biopharmaceutical company specialising in novel small molecule therapeutics to treat neurological and cardiovascular diseases Nyrada (ASX:NYR) today announced positive results from its preclinical study evaluating the efficacy of its brain injury program drug candidate NYR-BI03 in preventing secondary brain injury.
Bastion Minerals (ASX:BMO)says four over-range samples have been re-analysed on its highly prospective high-grade REE and copper project at its Gyttorp project in Sweden, returning values of between 2.5% and 8.5% copper.
Medical data and technology company focusing on digital transformation of maternity care HeraMED (ASX:HMD), has inked a two-year deal with Broward Health in Florida for a controlled rollout of its HeraCARE platform and HeraBEAT devices with implementation to start immediately and scale to support 700 pregnancies. According to the announcement total consideration for the deal is up to US$400k.
LOSERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Code | Company | Price | % | Volume | Market Cap |
|---|---|---|---|---|---|
| OPN | Openn Negotiation | 0.008 | -27% | 310,001 | $12,420,976 |
| IR1 | Iris Metals | 0.39 | -26% | 367,048 | $68,005,866 |
| E79 | E79 Gold Mines | 0.05 | -25% | 166,384 | $5,449,384 |
| TTI | Traffic Technologies | 0.007 | -22% | 375,256 | $6,819,032 |
| MME | Moneyme Limited | 0.071 | -17% | 1,179,391 | $68,806,749 |
| DUG | DUG Tech | 2.12 | -17% | 677,065 | $301,214,634 |
| GNM | Great Northern | 0.017 | -15% | 171,334 | $3,092,582 |
| W2V | Way2Vatltd | 0.023 | -15% | 9,531,719 | $17,593,428 |
| BUS | Bubalus Resources | 0.115 | -15% | 60,000 | $4,343,446 |
| BPP | Babylon Pump & Power | 0.006 | -14% | 72,593 | $17,496,843 |
Iris Metals (ASX:IR1) has successfully concluded the maiden RC drill program at its Beecher project in South Dakota with final results including 51m @ 1.26% Li2O from 38m adding to the numerous high grade and wide intercepts achieved. Very high grade intersections of up to 3.75m @ 3.00% Li2O have also been received from ongoing diamond drilling.
Way2VAT (ASX:W2V) says it has received firm commitments from new and existing institutional, professional and sophisticated investors to raise ~$4.25 million from the issue of ~193.2 million fully paid ordinary shares in the company at an issue price of 2.2 cents/share.
